<?xml version="1.0" encoding="UTF-8"?>
<p id="Par49">Our analyses confirmed the poor interest in ZIKAV R&amp;D prior to 2015 and the striking S&amp;T response after the LAC epidemics when severe clinical complications were attributed to the infection. WHO’s appeal for the opening of data and research information on ZIKAV was probably among the factors that promoted such a rapid reaction from the scientific community. It directly influenced the scientific communication by encouraging journals to “fast track” ZIKAV-related publications [
 <xref ref-type="bibr" rid="CR22">22</xref>]. This increase in R&amp;D activities was also bolstered by the funding made available by several international agencies [
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>].
</p>
